Zenas BioPharma Balance Sheet (2023-2025) | ZBIO

Balance Sheet Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Assets
Current Assets
Cash & Equivalents 72.31M56.86M37.15M183.93M360.04M319.74M314.20M274.90M301.60M
Short-term Investments 0.09M0.09M0.09M31.02M115.83M229.27M175.32M
Cash & Current Investments 72.31M56.86M37.24M184.02M360.13M350.77M430.02M504.17M476.92M
Prepaid Assets 2.95M6.98M5.07M5.43M5.32M5.76M
Current Assets 59.80M393.78M355.92M317.81M278.60M296.64M
Non-Current Assets
Property, Plant & Equipment (Net) 0.19M0.15M0.18M0.07M0.06M0.05M
Long-Term Investments 1.83M1.61M10.72M
Other Non-Current Assets 0.09M7.28M9.02M12.86M12.85M11.80M13.80M
Non-Current Assets 8.38M9.65M14.04M15.96M14.48M25.38M
Assets 68.18M403.43M369.97M333.77M293.08M322.02M
Liabilities
Current Liabilities
Accounts Payables 5.40M15.08M17.14M20.02M7.93M6.44M
Payables 5.40M15.08M17.14M20.02M7.93M6.44M
Accumulated Expenses 17.31M28.53M39.37M28.21M44.52M45.36M
Other Accumulated Expenses 0.11M0.33M0.25M0.38M0.51M0.58M
Current Leases 0.56M0.38M0.79M0.91M0.79M0.62M
Current Taxes 0.30M0.21M0.01M
Total Current Liabilities 23.26M44.00M57.29M49.13M53.24M52.42M
Non-Current Liabilities
Non-Current Debt 72.99M
Convertible Debt 20.30M
Preferred Stock Liabilities 193.29M250.09M
Operating Leases 0.26M0.22M0.32M0.21M0.18M
Other Non-Current Liabilities 20.30M
Total Non-Current Liabilities 23.52M0.22M73.17M
Total Liabilities 43.81M44.00M57.51M49.45M53.46M125.59M
Shareholder's Equity
Total Debt 72.99M
Common Equity -202.23M-225.72M-252.50M-288.78M359.44M312.46M284.32M239.63M196.43M
Shareholder's Equity -202.23M-225.72M-252.50M-288.78M359.44M312.46M284.32M239.63M196.43M
Liabilities and Shareholders Equity 68.18M403.43M369.97M333.77M293.08M322.02M
Retained Earnings -230.40M-334.80M-387.39M-421.00M-473.20M-524.70M
Treasury Shares 0.03M0.02M0.02M0.51M0.53M